SCILIPOTI: "Norme riguardanti l'informazione scientifica sui farmaci" (3507)

This procedure concerns the establishment of standards for providing scientific information regarding medicinal products. It aims to ensure that the data used to describe the efficacy and safety of drugs is accurate, transparent, and consistent across the healthcare sector. This will primarily affect pharmaceutical companies, healthcare providers, and regulatory bodies responsible for drug approvals and monitoring.